Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-Life Experience With First-Line Therapy Bortezomib Plus Melphalan and Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma Ineligible for High Dose Chemotherapy With Autologous Stem-Cell Transplantation.
Buda G, Del Giudice ML, Antonioli E, Ghio F, Orciuolo E, Morganti R, Martini F, Staderini M, Galimberti S, Petrini M. Buda G, et al. Among authors: del giudice ml. Front Med (Lausanne). 2021 Aug 27;8:712070. doi: 10.3389/fmed.2021.712070. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34513878 Free PMC article.
Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study.
Del Giudice ML, Gozzetti A, Antonioli E, Orciuolo E, Ghio F, Ciofini S, Candi V, Fontanelli G, Attucci I, Formica G, Bocchia M, Galimberti S, Petrini M, Buda G. Del Giudice ML, et al. Medicina (Kaunas). 2021 Aug 28;57(9):900. doi: 10.3390/medicina57090900. Medicina (Kaunas). 2021. PMID: 34577823 Free PMC article.
Risk of SARS-CoV-2 infection and severe COVID-19 in hematological patients who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab: a target trial emulation.
Falcone M, Tiseo G, Marchetti G, Kalo J, Galfo V, Occhineri S, Almerigogna F, Matucci T, Riccardi N, Suardi LR, Rina I, Sijoni L, Caparello MC, Cassano Cassano R, Del Giudice ML, Franciosa M, Facella F, Tancredi G, Fazzi R, Galimberti S. Falcone M, et al. Among authors: del giudice ml. Leuk Lymphoma. 2024 Jun 4:1-8. doi: 10.1080/10428194.2024.2361099. Online ahead of print. Leuk Lymphoma. 2024. PMID: 38832710
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy.
Ruglioni M, Crucitta S, Luculli GI, Tancredi G, Del Giudice ML, Mechelli S, Galimberti S, Danesi R, Del Re M. Ruglioni M, et al. Among authors: del giudice ml. Crit Rev Oncol Hematol. 2024 Sep;201:104424. doi: 10.1016/j.critrevonc.2024.104424. Epub 2024 Jun 23. Crit Rev Oncol Hematol. 2024. PMID: 38917943 Free article. Review.
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis.
Cassano Cassano R, Genovesi D, Vergaro G, Giorgetti A, Aimo A, Del Giudice ML, Galimberti S, Emdin M, Buda G. Cassano Cassano R, et al. Among authors: del giudice ml. Eur J Clin Invest. 2024 Jul 17:e14270. doi: 10.1111/eci.14270. Online ahead of print. Eur J Clin Invest. 2024. PMID: 39021058
14 results